SYP and Alzheimer disease: Thirdly, we noticed changes in brain integrity markers, including PSD95, Iba1, GFAP, and Synaptophysin, as seen in vulnerable regions in AD brain in humans (Braak and Braak, 1991; Leuba et al., 2008).